好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Cerebrovascular Disease

Friday 05/04/07
09:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Full-Day Course
S. C. Johnston, MD, PhD, FAAN
Participants should become familiar with the latest recommendations, and some controversies, on evaluation and treatment of patients with cerebrovascular disease, including appropriate use and interpretation of MRI, MRA, and CT; new evidence on statins and antiplatelet agents; recent insights on management of TIA; methods for improving adherence to proven therapies; and recent evidence guiding treatment of unruptured aneurysms, carotid stenosis, and intracerebral hemorrhage.
No CME available
Medical Knowledge
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
09:00 AM - 09:35 AM Advances in Stroke Imaging
Steven Warach, MD, PhD
09:35 AM - 10:10 AM The Role of Carotid and Intracranial Stenting
Thomas G. Brott, MD, FAAN
10:10 AM - 10:45 AM Treatment of Unruptured Intracranial Aneurysms
Robert D. Brown, Jr., MD, MPH, FAAN
10:45 AM - 11:00 AM Break
11:00 AM - 11:35 AM Management of Intracerebral Hemorrhage
Stephan A. Mayer, MD
11:35 AM - 12:00 PM Discussion
12:00 PM - 01:30 PM Lunch
01:30 PM - 02:05 PM Rethinking TIA
S. C. Johnston, MD, PhD, FAAN
02:05 PM - 02:40 PM Statins and Stroke
Ralph L. Sacco, MD, MS, FAHA
02:40 PM - 03:15 PM Strategies to Improve Care After Stroke
Bruce I. Ovbiagele, MD, MSc, FAAN
03:15 PM - 03:45 PM Break
03:45 PM - 04:20 PM Antiplatelet Therapy: Bringing ESPRIT to Treatment
J. D. Easton, MD, FAAN
04:20 PM - 05:00 PM Discussion: Evidence and Opinion in Therapy
Faculty Disclosures
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
S. C. Johnston, MD, PhD, FAAN No disclosure on file
Ralph L. Sacco, MD, MS, FAHA Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Stephan A. Mayer, MD Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
J. D. Easton, MD, FAAN No disclosure on file
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Steven Warach, MD, PhD Dr. Warach has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Warach has received research support from State of Texas. Dr. Warach has received publishing royalties from a publication relating to health care.